Rofecoxib

0Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

Abstract

Rofecoxib, a nonsteroidal antiinflammatory agent, is a selective inhibitor of cyclooxygenase 2 with analgesic and antipyretic activities. Its pharmacological effects are thought to be due to reduction of prostaglandin synthesis. Merck and Co. Inc. voluntarily withdrew product (Vioxx) from the global market in September of 2004 after a colon cancer trial confirmed concerns the drug raises the risk of .... © 2007 Elsevier Inc.

Cite

CITATION STYLE

APA

Miles, S. (2011). Rofecoxib. In xPharm: The Comprehensive Pharmacology Reference (pp. 1–6). Elsevier Inc. https://doi.org/10.1016/B978-008055232-3.62555-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free